ONDANSETRON 8 mg / 4 mL Vial

Antiemetic – 5-HT3 Receptor Antagonist

---

Product Description:

Ondansetron is a selective serotonin 5-HT3 receptor antagonist indicated for the prevention and treatment of nausea and vomiting associated with chemotherapy, radiotherapy, and surgical procedures. It functions by blocking serotonin receptors both centrally in the chemoreceptor trigger zone and peripherally in the gastrointestinal tract, making it a cornerstone of antiemetic therapy in oncology and perioperative care.

Available Presentation:

• Strength: 8 mg / 4 mL (2 mg/mL)
• Form: Injectable Solution
• Packaging: Single-use vial (4 mL)
• Route of Administration: Intravenous (IV) or Intramuscular (IM)
• Storage: Store below 25°C; protect from light

Uses:

• Prevention of chemotherapy-induced nausea and vomiting (CINV)
• Control of radiotherapy-induced nausea and vomiting (RINV)
• Prevention and treatment of postoperative nausea and vomiting (PONV)
• Supportive care in oncology, surgical, and emergency medicine

Indications:

• CINV: For use during initial and repeat courses of emetogenic chemotherapy
• RINV: Indicated in patients receiving total body or abdominal radiation
• PONV: Prevention and management in adults and children ≥1 month of age

Regulatory and Safety Information:

• ATC Code: A04AA01
• WHO Essential Medicines List: Yes
• Pharmacologic Class: Selective 5-HT3 receptor antagonist
• Contraindications: Known hypersensitivity to Ondansetron or other 5-HT3 antagonists
• Precautions: May prolong QT interval; monitor in patients with cardiac conditions
• Common Adverse Effects: Headache, constipation, fatigue, transient liver enzyme elevation

---

For bulk orders, regulatory support, and institutional supply inquiries, please contact our commercial team at info@panamfarma.com.